Similar articles

• [Guidelines in the management of H. pylori infection in Japan].

  Asaka M. Asaka M. Nihon Rinsho. 2005 Nov;63 Suppl 11:12-6. Nihon Rinsho. 2005. PMID: 16363496 Review. Japanese. No abstract available.
• [Helicobacter pylori eradication therapy for children].

  Konno M. Konno M. Nihon Rinsho. 2005 Nov;63 Suppl 11:470-3. Nihon Rinsho. 2005. PMID: 16363581 Review. Japanese. No abstract available.
• [Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].

  Mitsuno Y, Yoshida H. Mitsuno Y, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:452-4. Nihon Rinsho. 2002. PMID: 11979826 Clinical Trial. Japanese. No abstract available.
• [Adverse effects of Helicobacter pylori eradication and its prevention].

  Zhang S, Yanaka A. Zhang S, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:414-7. Nihon Rinsho. 2005. PMID: 16363570 Review. Japanese. No abstract available.
• [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].

  Nagahara A, Sato N. Nagahara A, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:421-5. Nihon Rinsho. 2005. PMID: 16363572 Review. Japanese. No abstract available.